Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.24.1.u1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data) Three Months Ended March 31,
  2024 2023
Numerator
Net increase (decrease) in net assets resulting from operations $ 90,964  $ 94,564 
Less: Total distributions declared (76,031) (64,774)
Total Earnings (loss), net of total distributions 14,933  29,790 
 
Earnings (loss), net of distributions attributable to common shares 14,776  29,442 
Add: Distributions declared attributable to common shares 75,230  64,023 
Numerator for basic and diluted change in net assets per common share $ 90,006  $ 93,465 
 
Denominator
Basic weighted average common shares outstanding 157,445 135,252
Common shares issuable 475 1,804
Weighted average common shares outstanding assuming dilution 157,920 137,056
 
Change in net assets per common share:
Basic $ 0.57  $ 0.69 
Diluted $ 0.57  $ 0.68 
Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three months ended March 31, 2024, and 2023, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended March 31,
Anti-dilutive Securities 2024 2023
Unvested common stock options 2,004 1,853
Restricted stock units — 7,874
Unvested restricted stock awards 895 54,361